British drugmaker GSK moves mRNA flu vaccine to late-stage trials
(Reuters) -British drugmaker GSK announced on Thursday positive results from a mid-stage trial of its seasonal influenza ...
GSK Says mRNA Flu Shot Shows Promise in Boost for Pipeline
GSK Plc’s experimental mRNA flu vaccine showed a positive immune response against two key types of flu viruses in a mid-stage ...
Seeking Alpha on MSN7d
GSK, CureVac mRNA flu shot reaches late-stage studies
“This marks a significant advancement in our mRNA programme and these data support moving into late-stage development,” GSK’s ...
pharmaphorum7d
GSK drops HSV jab, leaving rival mRNA shots in pole position
GSK has abandoned its clinical-stage vaccine for herpes simplex virus (HSV) after a disappointing phase 1/2 trial, ceding the ...
FierceBiotech7d
GSK's mRNA flu vaccine finally overcomes tricky B strains in phase 2 trial
After an initial defeat against the biggest barrier to mRNA flu vaccines—namely, B strains of influenza—GSK has returned with a reformulated candidate that has ...
The Pharma Letter6d
GSK presents positive mRNA seasonal influenza vaccine data
GSK announced positive Phase II results for its mRNA seasonal influenza vaccine, showing strong immune responses against ...
EuropaWire7d
GSK’s mRNA Flu Vaccine Candidate Moves to Phase III After Positive Phase II Results
GSK has reported positive results from its phase II trial for an mRNA seasonal influenza vaccine candidate, showing strong immune responses again ...
GSK Announces Promising Data From Phase II Seasonal Influenza MRNA Vaccine Program
Thursday announced positive data from a phase II trial for its mRNA seasonal influenza vaccine programme. The study ...
GSK reports positive results from mRNA flu vaccine trial
GSK announced promising results from its phase two clinical trial for an mRNA-based seasonal flu vaccine on Thursday.
PipelineReview.com7d
GSK announces positive headline data from phase II seasonal influenza mRNA vaccine programme
LONDON, UK I 12, 2024 I GSK plc (LSE/NYSE: GSK) today announced positive headline results of a phase II trial (NCT06431607) for its mRNA seasonal ...
Daily6d
After positive midstage trial, GSK moves mRNA flu vaccine to late-stage trials
British drugmaker GSK announced on Thursday positive results from a mid-stage trial of its seasonal influenza vaccine ...
London South East7d
GSK reports positive results from mRNA flu vaccine trial
(Sharecast News) - GSK announced promising results from its phase two clinical trial for an mRNA-based seasonal flu vaccine on Thursday. The FTSE 100 pharmaceuticals giant said the study ...